Aim: To obtain preliminary safety and efficacy data on intravenous (IV) administration of infliximab (IFX) and ferric carboxymaltose (FCM) to inflammatory bowel disease (IBD) patients in a single treatment session.
Cortes X, Borrás-Blasco J, Molés JR, Boscá M, Cortés E (2015)
PLoS ONE 10(5): e0128156. doi:10.1371/journal.pone.0128156